Thursday, November 06, 2014 12:25:17 PM
We've also had a lot of new eyes on the board recently, so it may be educational for them as well.
My first few thousand shares were bought back in the mid-.30s, but I've been adding periodically due to the science and potential here. For all those concerned with a little pullback here, realize that over the last 3 years, we've enjoyed a 10 bagger here. It's not like this is our first pullback in all that time, either...
Making up future prices is an exercise in creative writing. And making up reasons for pullbacks when we don't really have concrete information is the same. Microcaps can and will be manipulated. Small and Mid-cap will be, as well. And large caps can over-react to rumors and news as well. Systems develop because of patterns and trends. Enough people believing in something make it truth, at least until a new truth comes along. So many computers and algorithms moving so many more shares than ever before can skew volatility. Markets are not rational because the ultimate decision making is still made by people.
Good companies, with good science/technology/models, good leadership, and flexibility have always done better in the long term. With a whole antibiotic/anti-inflammatory platform to develop, a cancer treatment that works alone on at least a couple of forms of cancer and could be beneficial in combination with current main-stream treatments (i.e. it's not the sort of threat that big-pharma is likely to shut down b/c it could make a great sidekick), and a targeted psoriasis drug, and a whole slew of compounds yet to be fully explored, this little biotech has a lot more going for it than most of us can fully appreciate.
Can you really blame our CEO for sounding a little excited at times? Or for being slightly inconsistent in his language or phrasing? IND prep to oversee, CROs to manage, FDA meetings, travel to visit suppliers and potential investors, financials to review and submit, drug development to keep track of, exchange registration and uplisting to worry about, a board of directors to develop, shelf registrations to secure potential future financing, intelligently managing the Aspire deal that's let us get this far, the Aruda issues, conferences and presentations, interviews to prepare for, PRs to develop, and probably a lot more that we don't realize. (Not to mention, he still has a family and theoretically a life outside of CTIX.) He has a lot going on. CTIX has a lot going on.
Much thanks to Big Kahuna, KarinCA, BioHedge, EtradeEdge, Ovidius, the Monolith, INH, Wild, Addict, Gov, the Dane, ShinSekai, Apparition, Dr. J/George, all the TA guys, Smitty, the Toms, the traders, the longs, the excited, and the worried for making this the best board and a good daily read. My apologies to any I forgot. It's a nice community here. Very knowledgeable, willing to share, and diverse. But all here for the same reason.
Cheers to all!
GO CTIX!
-ro
Recent IPIX News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/01/2024 01:30:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2023 09:25:58 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 09:05:44 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/15/2023 01:00:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2023 08:15:25 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 09/28/2023 01:00:08 PM
FEATURED NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM